KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) EPS (Weighted Average and Diluted) (2023 - 2024)

Historic EPS (Weighted Average and Diluted) for BioNTech SE (BNTX) over the last 2 years, with Q4 2024 value amounting to $240277.8.

  • BioNTech SE's EPS (Weighted Average and Diluted) rose 596.01% to $240277.8 in Q4 2024 from the same period last year, while for Dec 2024 it was $240277.8, marking a year-over-year increase of 596.01%. This contributed to the annual value of -$638981.5 for FY2024, which is 1550616015.32% down from last year.
  • Latest data reveals that BioNTech SE reported EPS (Weighted Average and Diluted) of $240277.8 as of Q4 2024, which was up 596.01% from $244567.9 recorded in Q3 2024.
  • In the past 5 years, BioNTech SE's EPS (Weighted Average and Diluted) registered a high of $244567.9 during Q3 2024, and its lowest value of $82783.5 during Q3 2023.